56TH ERA-EDTA CONGRESS OFFICIAL WEBSITE

ERA-EDTA BUD2019 banner 900x344 0418-1.jpg
ERA-EDTA BUD2019 banner 900x344 0418-2.jpg
ERA-EDTA BUD2019 banner 900x344 0418-3.jpg
panorama.jpg
Budapest-Citadella-s.jpg
Panorama-with-the-Chain-Bridge-s.jpg
panorama_3.jpg
panorama-4.jpg

Abstract Submissions


Submit your abstract

 
Communications should concern all aspects of nephrology, the prevention and treatment of renal diseases and associated conditions and/or the scientific background to the study of the kidney.

GENERAL RULES
All abstracts must be submitted electronically. Click here to submit your abstract.

All abstracts must be received by January 25, 2019.

Abstracts received after this date will not be considered by the Paper Selection Committee.

CONFIRMATION
You will automatically receive an e-mail confirming our receipt of your abstract.

NOTIFICATION
The Presenting Author of each accepted abstract will be notified by April 3, 2019. If the Presenting Author is unable to present the abstract, another co-author can take his/ her place. However, if this is the case, a letter from the Presenting Author about the change is requested and it must be received by the ERA-EDTA Operative Headquarters no later than April 30, 2019.

WITHDRAWAL / CHANGES
Submitted abstracts cannot be withdrawn or changed. No exceptions will be made.

CONTENT OF WORK AGREEMENT
The presenting author must confirm that all co-authors agree with the submission and content of the abstract. ERA-EDTA cannot be deemed responsible for any infringement of this rule.

COPYRIGHT
By submitting the abstract, the author assigns copyright to the ERA-EDTA. ORIGINAL ABSTRACTS Submitted abstracts must describe unpublished work that is not already in press or awaiting possible acceptance by any other society that publishes its abstracts/proceedings.

LANGUAGE
All abstracts must be written in English.

PROCESSING FEE
A non-refundable processing fee of EUR 25.00 must be paid for each abstract submitted. The processing fee must be paid at the time of submission by credit card only. Major credit cards (American Express, MasterCard and Visa) are accepted for the secure online payment. All payments must be received by Friday, January 25, 2019 at 23.59 CET so that the submission can be finalised succesfully. This fee is non refundable even if the abstract is rejected.
Abstract processing fees are waived for submitters from countries with an official annual income (GDP - Gross Domestic Product per Capita) below USD 10,000 (source:World Bank). A list of eligible countries can be accessed here.

HOW TO SUBMIT ABSTRACTS
Click here to submit your abstract and follow the instructions for abstract submission. You can submit your abstracts from November 6, 2018. Only submission through the congress website is possible. Abstracts sent by post or e-mail will not be accepted. All authors of correctly written and successfully submitted abstracts will receive confirmation by e-mail. Should you experience any unforeseen problems with the electronic submission, please contact the ERA-EDTA Operative Headquarters at abstracts@era-edta.org.

PUBLICATION
All abstracts accepted for presentation (either oral or poster) will appear in NDT as an official supplement. Abstracts will appear exactly as submitted. Any abstract considered unsuitable for reproduction will not be published.

LATE BREAKING CLINICAL TRIALS
The ERA-EDTA will consider abstracts related to unpublished clinical trials for a special “Late breaking clinical trials” session. The following trials will be considered for evaluation if they comply with the required characteristics: - a prospective randomised intervention in renal patients (medication, education, dietetics, physiotherapy, etc…), including at least 100 patients; - a prospective observational study, including at least 500 patients; - approved by an institutional ethical committee; - not previously reported or published. Abstracts may be accepted as oral communications or posters, after being evaluated by the review committee. The LBCT abstracts must be submitted through the congress website from March 6 to 29, 2019. Abstracts that do not meet the criteria above will not be considered for presentation.

FREE COMMUNICATIONS
The highest scoring abstracts will be presented as free communications, combined with mini lectures from world renowned scientists.

POSTERS
There will be two poster sessions (June 14 and 15, 2019). Posters will be sorted by topic and will remain on display from 7.30 to 17.00 hrs. Presenters must be by their poster during the dedicated session times (9.30-10.45 and 16.30-17.00) to discuss their research with the visiting audience. It will be possible to browse all posters online both onsite (in the e-posters zone) and after the congress on the European Nephrology Portal (ENP - https://www.enp-era-edta.org). This year, once again, the ERA-EDTA is pleased to provide all poster presenters with the opportunity of having their posters printed and delivered free of charge to the congress venue.

 

European Renal Association - European Dialysis and Transplant Association (ERA-EDTA)
Data Privacy Statement

During the congress, attendees, exhibitors, guests and others may be photographed and videotaped by ERA-EDTA or its partners capturing the event. Some of these photographs or videos may be displayed by the ERA-EDTA or its partners in future publications or materials connected with the event. If you do not wish for your image to be displayed by the ERA-EDTA, please contact the ERA-EDTA in writing at secretariat@era-edta.org . Without contradictory instructions from your side, you hereby grant the European Renal Association - European Dialysis and Transplant Association (ERA-EDTA), the irrevocable right to use your image, voice, name, photographs, and video for purposes related to Scientific and Educational Purposes. You hereby release, waive and discharge the European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) its employees and independent contractors from any and all demands, claims, causes of action, damages and liabilities directly or indirectly arising out of any use of your image, voice or name pursuant to the foregoing rights grant.